Chapter President "Back of the Envelope" Pediatrician Poll

From Dr. Mary Beth Miotto, your MCAAP President:

Last month's survey was on how your practice has experienced Nirsevimab/Beyfortus (RSV monoclonal antibody) distribution in early 2024. We heard back from the majority of you that you had not received new stock in months and we subsequently shared feedback to the DPH Immunization program that there is more transparency requested on this issue. 

This month's simple question is multiple-choice. Check all that apply and feel free to add your specific comments:

When the MCAAP offers educational programs (including the Annual Meeting, educational series, and standalone programs), would you prefer us to offer?

• CME credit
• MOC Part 2 credit
• The credit is not as important to me as the opportunity (e.g. I don't care)
• I would like more opportunities that offer MOC Part 4 credit 

Click here to complete the poll.

Please share the link with member and non-member pediatricians.